This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Proteostasis Therapeutics, Inc.
Drug Names(s): PTI808, PTI 808
Description: PTI-808 is a potentiator molecule under development by Proteostasis.
Additional information available to subscribers only: